Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental parkinsonism.
Dajas
F
F
Department of Neurochemistry, Clemente Estable Institute of Biology, Montevideo, Uruguay. fdajas@iibce.edu.uy
Costa
G
G
Abín-Carriquiry
J A
JA
McGregor
R
R
Urbanavicius
J
J
D000818:Animals; D019610:Cytoprotection / Q000502:physiology*; D004298:Dopamine / Q000502:physiology*; D066298:In Vitro Techniques; D009411:Nerve Endings / Q000503:physiopathology*; D018696:Neuroprotective Agents / Q000494:pharmacology; D009498:Neurotoxins; D009538:Nicotine / Q000494:pharmacology; D016627:Oxidopamine; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000503:physiopathology*; D011978:Receptors, Nicotinic / Q000502:physiology*
D018696:Neuroprotective Agents; D009498:Neurotoxins; D011978:Receptors, Nicotinic; D009538:Nicotine; D016627:Oxidopamine; D004298:Dopamine